It's obvious Spender has no idea about the drug/therapy development process, value of patents, potential returns to be made from our innovative game changing technology, and our late stage research/ highly efficacious and safe results for areas of largely unmet need (results further supported/enhanced by biomarkers), the both niche and large markets we are in, and not to mention our near term regulatory hopefuls (one most likely on the cusp of FDA approval, another given guidance on a clear pathway for an EUA, other pathway to be announced in the coming weeks/months).
What's with these uninformed flickers popping up... An Edwin lookalike maybe...
MSB Trading 2021 - paradigm shift, page-9178
-
- There are more pages in this discussion • 1,033 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |